Nektar Therapeutics (NKTR) Receivables - Other (2018 - 2024)
Historic Receivables - Other for Nektar Therapeutics (NKTR) over the last 7 years, with Q4 2024 value amounting to $1.1 million.
- Nektar Therapeutics' Receivables - Other rose 12000.0% to $1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year increase of 12000.0%. This contributed to the annual value of $1.1 million for FY2024, which is 12000.0% up from last year.
- Nektar Therapeutics' Receivables - Other amounted to $1.1 million in Q4 2024, which was up 12000.0% from $500000.0 recorded in Q4 2023.
- In the past 5 years, Nektar Therapeutics' Receivables - Other registered a high of $6.2 million during Q1 2020, and its lowest value of $500000.0 during Q4 2023.
- Moreover, its 5-year median value for Receivables - Other was $3.2 million (2020), whereas its average is $3.3 million.
- Per our database at Business Quant, Nektar Therapeutics' Receivables - Other crashed by 7254.9% in 2021 and then surged by 12000.0% in 2024.
- Quarter analysis of 5 years shows Nektar Therapeutics' Receivables - Other stood at $5.1 million in 2020, then crashed by 72.55% to $1.4 million in 2021, then tumbled by 50.0% to $700000.0 in 2022, then fell by 28.57% to $500000.0 in 2023, then surged by 120.0% to $1.1 million in 2024.
- Its Receivables - Other stands at $1.1 million for Q4 2024, versus $500000.0 for Q4 2023 and $700000.0 for Q4 2022.